Cancer

22 December 2011

Single gene links rare cancers

Canadian researchers have discovered that a common gene links a number of rare reproductive cancers, a finding that could lead to new approaches for treatment, said a study.

0

Canadian researchers have discovered that a common gene links a number of rare reproductive cancers, a finding that could lead to new approaches for treatment, said a study published.

Ovarian, uterine and testicular cancer were all found to have the same mutation in a gene called DICER, said the research in the New England Journal of Medicine.

Scientists have known about DICER for many years, but its exact role in sparking tumour cells to grow has been unclear.

When the gene mutates, DICER's function is changed "so that it participates directly in the initiation of cancer, but not in a typical on-off fashion," said co-author Gregg Morin, a lead scientist from the Michael Smith Genome Sciences Centre at the British Columbia Cancer Agency.

Role of DICER in other cancers

"DICER can be viewed as the conductor for an orchestra of functions critical for the development and behaviour of normal cells," explained co-author Gregg Morin, a lead scientist from the Michael Smith Genome Sciences Centre at the British Columbia Cancer Agency.

The mutations we discovered do not totally destroy the function of DICER, rather they warp it – the orchestra is still there but the conductor is drunk.

Researchers are examining whether DICER plays a role in other cancers, and will investigate if mutant DICER can be manipulated to treat the cancers it causes.

Ovarian cancer kills about 15 000 women in the United States each year, and about 22,000 new cases are diagnosed annually.

Testicular cancer rear in US

More than 46 000 cases of uterine cancer and 8 100 deaths arise each year in the United States. Testicular cancer is rarer, with 8 300 new cases per year and 350 US deaths, according to the American Cancer Society.

"This breakthrough will be of interest to both the clinical and the fundamental science communities," said Phillip Sharp, Institute Professor at the Massachusetts Institute of Technology and co-winner of the 1993 Nobel Prize in Physiology and Medicine for the discovery of the structure of genes.

"Huntsman, Morin and colleague's very exciting discovery of specific mutations in DICER, a factor essential for syntheses of small regulatory RNAs in ovarian and other human tumours, could lead to new approaches to treatment."

 (Sapa, December 2011) 

Read more:

Cancer
Testicular cancer

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules